Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Free Cash Flow (2024 - 2025)

Beta Bionics' Free Cash Flow history spans 2 years, with the latest figure at -$10.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 29.04% year-over-year to -$10.5 million; the TTM value through Dec 2025 reached -$56.2 million, down 8.81%, while the annual FY2025 figure was -$56.2 million, 8.81% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$10.5 million at Beta Bionics, up from -$12.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$10.5 million in Q4 2025 and bottomed at -$20.3 million in Q1 2025.